HC SURGICAL SPECIALISTSLIMITED
(SGX: 1B1)

HC Surgical Specialists Limited and its subsidiaries are engaged in the medical services business. The Company is engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of clinics located throughout Singapore. It is engaged in providing medical care, consultancy, treatment and surgery in the field of colorectal endoscopy, vein and vascular. Its clinics are equipped with the facilities needed to perform a range of procedures on-site, including endoscopic procedures and other minor surgical services. The Company treats a range of conditions, including hemorrhoids, anal abscesses, anal fissures, gallstones and inflammation of the gallbladder, hernias, colorectal cancer, stomach cancer, colonic diverticular disease, and cysts and lipomas. The Company's clinics are located in central Singapore, as well as, in residential areas, including the heartlands.

0.260 CD

- (-%)
Range 0.260 - 0.265   (1.92%)
Open 0.265
Previous Close 0.260
Bid Price 0.260
Bid Volume ('000) 24.6
Ask Price 0.270
Ask Volume ('000) 43.7
Volume ('000) 26.4
Value 6,869
Remark CD
Delayed prices. Updated at 06 Sep 2024 17:04.
Data powered by

Upcoming Events

AGM

Meeting Date 26 September 2024
Meeting Time 2:00 PM
2.00 P.M. AT 131 RIFLE RANGE ROAD, LEVEL 3 SELETAR I ROOM, TEMASEK CLUB, SINGAPORE 588406.

EGM

Meeting Date 26 September 2024
Meeting Time 3:00 PM
3.00 P.M. AT 131 RIFLE RANGE ROAD, LEVEL 3 SELETAR I ROOM, TEMASEK CLUB, SINGAPORE 588406.

Dividend

Ex-Date 08 November 2024
Record Date 11 November 2024
Payable Date 25 November 2024
DIVIDEND : SGD 0.007
Data powered by SGX.
View All Events

About HC Surgical

HC Surgical Specialists Limited and its subsidiaries are engaged in the medical services business. The Company is engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of clinics located throughout Singapore. It is engaged in providing medical care, consultancy, treatment and surgery in the field of colorectal endoscopy, vein and vascular. Its clinics are equipped with the facilities needed to perform a range of procedures on-site, including endoscopic procedures and other minor surgical services. The Company treats a range of conditions, including hemorrhoids, anal abscesses, anal fissures, gallstones and inflammation of the gallbladder, hernias, colorectal cancer, stomach cancer, colonic diverticular disease, and cysts and lipomas. The Company's clinics are located in central Singapore, as well as, in residential areas, including the heartlands.

Loading Chart...

Please login to view stock data and analysis